Efficacy and safety of CD22 chimeric antigen receptor (CAR) T cell therapy in patients with B cell malignancies: a protocol for a systematic review and meta-analysis
information for practice - Meta-analyses systematic reviews,
Chimeric antigen receptor (CAR) T cell therapy has had great success in treating patients with relapsed or refractory B cell…